Literature DB >> 17893154

Increased susceptibility to colistin in hypermutable Pseudomonas aeruginosa strains from chronic respiratory infections.

M D Maciá, A Mena, N Borrell, J L Pérez, A Oliver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17893154      PMCID： PMC2168005          DOI： 10.1128/AAC.00981-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  17 in total

1.  Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.

Authors:  María D Maciá; David Blanquer; Bernat Togores; Jaume Sauleda; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.

Authors:  R K Ernst; E C Yi; L Guo; K B Lim; J L Burns; M Hackett; S I Miller
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

3.  Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.

Authors:  Michael Hogardt; Sabine Schmoldt; Monika Götzfried; Kristin Adler; Jürgen Heesemann
Journal:  J Antimicrob Chemother       Date:  2004-10-27       Impact factor: 5.790

4.  Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections.

Authors:  Antonio Oliver; Bruce R Levin; Carlos Juan; Fernando Baquero; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

5.  The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.

Authors:  Antonio Oliver; Fernando Baquero; Jesús Blázquez
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

6.  Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.

Authors:  Oana Ciofu; Bente Riis; Tacjana Pressler; Henrik Enghusen Poulsen; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

Authors:  V Plasencia; N Borrell; M D Maciá; B Moya; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

8.  Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients.

Authors:  Olivia Gutiérrez; Carlos Juan; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains.

Authors:  R E Hancock; L M Mutharia; L Chan; R P Darveau; D P Speert; G B Pier
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

10.  Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion.

Authors:  Maria D Maciá; Nuria Borrell; José L Pérez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.